D. Hoppensteadt

发表

Isolation and characterization of human heparin.

J. Mulliken, J. Folkman, R. Linhardt, 1992, Biochemistry.

A Multicenter Evaluation of a Point-of-Care Blood Glucose Meter System in Critically Ill Patients.

Corinne R. Fantz, M. Goodman, R. Matika, 2021, The journal of applied laboratory medicine.

Low molecular weight dermatan sulfate as an antithrombotic agent. Structure-activity relationship studies.

U. R. Desai, R. Linhardt, J. Fareed, 1994, Biochemical pharmacology.

Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities.

A. Al-Hakim, R. Linhardt, J. Fareed, 1991, Biochemical pharmacology.

Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systems.

J. Fareed, D. Hoppensteadt, B. Kaiser, 1994, Thrombosis research.

Influence of recombinant hirudin and unfractionated heparin on thrombin and factor Xa generation in extrinsic and intrinsic activated systems.

F. Markwardt, J. Fareed, D. Hoppensteadt, 1992, Thrombosis research.

Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention.

C. Grines, D. Kereiakes, B. Brodie, 2001, The Journal of invasive cardiology.

The Hemostatic Effects of Warfarin Titration in Post CABG Patients in Comparison to Placebo Treatment

B. Hoogwerf, D. Hunninghake, J. Probstfield, 2001, Journal of Thrombosis and Thrombolysis.

Hemostatic Effects of 1 mg Daily Warfarin on Post CABG Patients

D. Hunninghake, J. Probstfield, M. Terrin, 1999, Journal of Thrombosis and Thrombolysis.

Oligosaccharide mapping of low molecular weight heparins: structure and activity differences.

A. Al-Hakim, R. Linhardt, J. Fareed, 1990, Journal of medicinal chemistry.

Modulation of vasoconstriction by clopidogrel and ticlopidine.

D. Hoppensteadt, J. Fareed, D. Hoppensteadt, 1998, Thrombosis research.

Report of the Subcommittee on Control of Anticoagulation on the determination of the anticoagulant effects of apixaban: communication from the SSC of the ISTH

C. Weiss, D. Hoppensteadt, J. Harenberg, 2014, Journal of thrombosis and haemostasis : JTH.

In vitro studies on the effect of activated protein C on platelet activation and thrombin generation.

J. Fareed, D. Hoppensteadt, W. Jeske, 1997, Thrombosis research.

Recombinant TFPI and variants: potential implications in the treatment of cardiovascular disorders.

D. Hoppensteadt, B. Kaiser, J. Fareed, 1998, Expert opinion on investigational drugs.

Comparative Studies on the Anticoagulant and Protease Generation Inhibitory Actions of Newly Developed Site-Directed Thrombin Inhibitory Drugs

J. Fareed, D. Hoppensteadt, D. Callas, 1995, Seminars in thrombosis and hemostasis.

Protamine sulfate neutralization of the anticoagulant activity of Aprosulate, a synthetic sulfated lactobionic acid amide.

Richard Kijowski, J. Fareed, D. Hoppensteadt, 1994, Thrombosis research.

Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082.

L. M. Smith, M. Blajchman, F. Ofosu, 1992, European journal of biochemistry.

Measurement of functional and immunologic levels of tissue factor pathway inhibitor. Some methodologic considerations

J. Fareed, D. Hoppensteadt, W. Jeske, 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Feasibility and preliminary efficacy of acupuncture for angina in an underserved diverse population

H. DeVon, A. Shroff, D. Hoppensteadt, 2021, Acupuncture in medicine : journal of the British Medical Acupuncture Society.

Acupuncture to Improve Symptoms for Stable Angina (AIMS-A): Study Protocol for a Randomized Controlled Trial (Preprint)

Alana D. Steffen, H. DeVon, A. Shroff, 2019 .

Molecular profiling and weight determination of heparins and depolymerized heparins.

J. Fareed, D. Hoppensteadt, J. Lormeau, 1995, Journal of pharmaceutical sciences.

Inhibitory effects of TFPI variants on thrombin and factor Xa generation in fibrinogen-deficient human plasma.

J. Fareed, D. Hoppensteadt, W. Jeske, 1994, Thrombosis research.

Pharmacokinetics of Enoxaparin in Patients Undergoing Percutaneous Coronary Intervention With and Without Glycoprotein IIb/IIIa Therapy

D. Argenti, B. Jensen, D. Heald, 2003, American journal of therapeutics.

Development of Recombinant Hirudin as a Therapeutic Anticoagulant and Antithrombotic Agent: Some Objective Considerations

D. Hoppensteadt, J. Fareed, D. Hoppensteadt, 1989, Seminars in thrombosis and hemostasis.

Biochemical and Pharmacologic Characteristics of Reviparin, a Low-Molecular-Mass Heparin

J. Fareed, D. Hoppensteadt, O. Iqbal, 1997, Seminars in thrombosis and hemostasis.